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Summary
Long-term H-2-heterozygous a - (a x b)F1 bone marrow (BM) chimeras prepared with
supralethal irradiation (1,300 rod) are devoid of Ia + host BM-derived antigen-presenting cells
(APC), but show quite strong host la expression in germinal centers, probably on follicular dendritic
cells (a class of nonhemopoietic stromal cells) . To examine whether la expression on these non-
BM-derived cells is capable ofinducing post-thymic tolerance ofT cells, thymectomized irradiated
(a x b)Fi mice were reconstituted with parent a stem cells and then, 6 mo later, given parent
a thymus grafts. As measured by primary mixed lymphocyte reactions and Vs expression, the
CD4+ cells differentiating in the thymus-grafted mice showed no detectable tolerance to the
H-2 (la) antigens of the host . To examine whether the thymus-grafted mice contained
immunologically significant quantities of host Ia antigens, long-term a - (a x b)F1 chimeras
were injected with normal strain a CD4+ cells ; the donor cells were recovered from thoracic
duct lymph of the chimeras and tested for host reactivity in vitro. The results showed that la
expression in the chimeras was sufficient to cause selective trapping of a substantial proportion
of host-la-reactive CD4+ cells soon after transfer and, at later stages, to induce strong priming.
Tolerance was not seen . The data place constraints on the view that T cell recognition of antigen
expressed on cells other than typical BM-derived APC leads to tolerance induction .
T cell tolerance toMHC molecules occurs largely in the
thymus (1, 2) . Tolerance reflects deletion of immature
T cells encounteringMHC molecules displayed on marrow-
derived APC, and, to a lesser extent, on epithelial cells. The
possibility that T cells can also be tolerized toMHC antigens
in the post-thymic environment is suggested by the finding
that transgenic mice in whichMHC molecules are expressed
selectively in the /3 cells of the pancreas (3, 4) show marked
tolerance to the transgenicMHC molecules . These and other
findings (5) imply that contact of matureT cells withMHC
molecules expressed on cell types other than typicalAPC can
lead to tolerance rather than immunity.
To investigate this question, we constructed thymus-grafted
mice under conditions designed to allow newly formed strain
a CD4+ T cells to make post-thymic contact with strain b
H-2 (Ia) antigens expressed selectively on non-bone marrow-
derived (NBMD) 1 cells . In a second model, mature strain a
'Abbreviations used in this paper: BM, bone marrow ; BMC, bone marrow
chimeras; BMR, bone marrow reconstituted; DC, dendritic cells ; FDC,
follicular dendritic cells;NBMD, non-bone marrow-derived; TDL, thoracic
duct lymph ; TG, thymus grafts; TX, thymectomized .
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CD4+ cells were exposed to la' (a x b)F1 NBMD cells on
adoptive transfer. No tolerance was seen in either model ; in-
deed, conspicuous priming resulted in the second model. The
data would thus appear to contradict the dogma that T cell
contact with antigen on "nonprofessional" APC leads to
tolerance .
Materials and Methods
Mice.
￿
Mice were bred at the breeding facility of the Research
Institute of Scripps Clinic.
Preparation ofThymusgraftedMice
￿
(B6 x CBA/J)F l mice were
thymectomized (Tx) at 6-8wk of age (6), exposed to heavy irradi-
ation (1,300-1,400 rad) 2-3wk later, and then, within 4 h, recon-
stituted intravenously with T-depleted bone marrow (BM) cells (N5
x 106BM cells treated with anti-Thy-1 mAb + C) (7) ; 5 wk or
6 mo later, the chimeras were grafted under the kidney capsule
with 1-d-old donor vs. host thymuses (three per mouse) exposed
to 1,100 rod in vitro (8) . The mice were kept in positive-pressure
isolators and given antibiotics in the drinking water. The mice were
killed at 9-10 wk post-grafting to prepare T cells.
MonoclonalAntibodies.
￿
mAbs specific for Thy-1.2 (Jlj, rat), heat-
stable antigen (j11d, rat), CD4 (GK1.5, rat), CD8 (3.168 .8, rat),
V011 (RR3-15, rat), V08.1 + 8.2 (KJ16-133, rat), and I-Ak(r. f,')
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(7) . We also used mAbs specific for Thy-1 .1 (19E12, mouse) (9),
Vs5 (MR9-4, mouse) (J . Bill et al ., manuscript in preparation),
I-E' (14.4.4, mouse) (10), and SM3Gi1 (3G11) (mouse) (11) .
Preparation ofBMChimeras.
￿
Chimeras usedfor histological anal-
ysis or as hosts for parental strain CD4+ cells were prepared by
exposing (B6 x CBA/J)F l or (B6 x CBA/Ca)F 1 mice to 1,300
rad followed by reconstitution intravenously with -5 x 106
T-depleted B6 or B6.PLBM cells (7) . All mice were left for at least
6mo before testing. After 6 mo, some chimeras were given a second
dose of irradiation (900-1,000 rad) followed by further reconstitu-
tion with parental strain BM cells (7) .
IFN-y TreatmentIn Viva
￿
Chimeras and control mice weregiven
four intraperitoneal injections of murine rIFN-y (80,000 U/injec-
tion) at daily intervals . Mice were used at day 4 after the first injec-
tion . IFN-y was kindly provided by Ryuji Maekawa (Shionogi
Research Laboratories, Osaka, Japan) .
Blood-to-Lymph Recirculation of T Cells through Irradiated Hosts.
Using a modification of a technique described elsewhere (12, 13),
long-term chimeras and control mice were exposed to 900 rad and
then, 4-6 h later, injected intravenously with a dose ofN8 x 10'
purified B6 CD4* cells (LN cells treated with a mixture of anti-
CD8 and Jlid mAb + C [14]) . Thoracic duct cannulas were in-
serted in the mice 16 h later and thoracic duct lymph (TDL) was
collected continuously on ice for several days. Lymph-borne cells
from two to four mice/group were washed and then stained for
surface markers or used as responder cells forMLR. Host-derived
cells in the lymph were quite rare (usually <10%) .
Mixed Lymphocyte Reactions .
￿
Using purified CD4* cells as re-
sponder cells, MLR were set up under standard conditions as de-
scribed elsewhere (14) .
FACS® Analysis.
￿
To detect cells expressing Vs TCR mole-
cules, lymphoid cells were stained with anti-Volt (rat) and anti-
V08 (rat) TCR mAbs followed by FITC-labeled H and L
chain-specific affinity-purified F(ab')a fragments of mouse anti-rat
IgG (PLl-Freez Biologicals, Rogers, AR), and with antiV05
(mouse)mAb followed by FITC-labeled goat anti-mouse IgG (Fc
fragment specific) (Cappel Laboratories, Malvern, PA) . In most ex-
periments, the cells were then stained with PE-labeled anti-CD4
mAb (BectonDickinson&Co., Mountain View, CA) . For staining
for Volt vs . 3G11, cells were incubated with biotinylated antiVo11
mAb and unconjugated 3G11 mAb followed by FITC-conjugated
rat anti-mouse IgG (H + L chain specific) (Jackson Im-
munoResearch, West Grove, PA) and PE-conjugated streptavidin
(Biomedia, Foster City, CA) . Cells were analyzed on a FACS IV®
flow cytometer (Becton Dickinson & Co.) .
Staining of Cryostat Sections.
￿
Freshly removed organs were
quickly frozen in liquid nitrogen, and 5-6-IA sections werecut with
a cryostat . The sections were briefly dried, fixed in acetone for 2
min, and incubated with optimal concentrations of biotinylated
antibodies for 1 h . After washing, horseradish peroxidase-conjugated
streptavidin Qackson ImmunoResearch) was added for an additional
30 min, washed, and incubated with the substrate 3-amino-9-
ethylcarbazole (Sigma Chemical Co., St . Louis, MO) (0.1 IAg/ml
in 0.05 M NaOAc pH 5.2) with 0.01% H ZOZ for 20 min . The
stained sections were then washed and photographed .
Results
To examine the tolerogenicity of Ia antigens expressed on
NBMD cells, parent a BM cells were allowed to differentiate
in parent a thymus grafts (TG) placed in Tx heavily irradi-
ated H-2 heterozygous (a x b)F i hosts . This model rests on
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the assumption that parent -+ F l bone marrow chimeras
(BMC) prepared with heavy irradiation express significant
levels ofhost Ia on stromal (NBMD) cells but lack host-derived
BM-derived cells. The extent of host Ia expression in BMC
is considered below.
Host Ia Expression in a -+ (a x b)F,BM Chimeras.
￿
When
(a x b)Fi mice are exposed to supralethal irradiation, e.g .,
1,300 rad, and reconstituted with parent a BM cells, Ia+
(H-2 class II') host cells with APC function in vitro disap-
pear rapidly (7) . By 2 mo post-transfer, virtually all func-
tionalAPC in suspensions of spleen and thymus are ofdonor
origin . Host Ia expression in cryostat sections of spleen from
a chimera tested at 6mo post-reconstitution is shown in Fig .
1 . Chimeras were constructed by transferring T-depletedB6.PL
(H-2b)BM cells to (B6 x CBA)Fi (H-2b x H-2k) mice ex-
posed to 1,300 rad. Cells expressing a high density of host
I-Ak or I-Ek molecules were not seen in the splenic red pulp
and were conspicuously absent from the periarteriolar lym-
phocyte sheaths (PALS) of the spleen and the marginal sinuses
of the white pulp borders, i .e., the regions occupied by den-
dritic (interdigitating) cells (DC) and macrophages, respec-
tively (Fig. 1, D-F) . Likewise, high-density I-Ak+ cells were
undetectable inLN, lung, liver, gut, and epidermis (data not
shown) . Nevertheless, moderately high I-Ak and I-Ek expres-
sion was observed in the central regions of primary follicles
and germinal centers . Since a similar pattern of staining was
observed in twice-irradiated chimeras given a total dose of
2,200 rad (see Materials and Methods), it is unlikely that the
Iak+ cells in primary follicles and germinal centers were BM
derived. The staining in these sites was probably restricted
to follicular dendritic cells (FDC) (15) . These cells are not
of hematogenous origin (16) and express significant though
variable levels of la molecules (16, 17) . FDC are not related
to typical BM-derived DC .
In addition to FDC, a low but variable level of host la
expression was evident on blood vessel endothelial cells of
the chimeras, especially in the red pulp. la expression on these
cellswas markedly elevated in chimeras injected with rIFN- ,y
(80,000 U daily for 4 d) (Fig . 1, G and H) .
The above findings confirm that parent -" Fl chimeras
prepared with supralethal irradiation are apparently devoid
of host-derived Ia+ BM-derived cells but do show significant
Ia expression on certain NBMD cells, especially FDC and
endothelial cells.
Antihost Reactivity ofCD4+ T Cells Developing in Tx (a x
b)F' Mice Given a BM Cell and a TG. Tx (B6 x CBA)F'
mice were exposed to heavy irradiation (1,300 rad) and recon-
stituted with Tdepleted Thy-1.1+ B6.PL (H-2b) BM . After
5 wk, these Tx, irradiated, BM-reconstituted (Tx.Ir.BMR)
mice received irradiated (1,100 rad) Thy-1.2+ B6 vs . (B6 x
CBA)Fi neonatal TG. PrimaryMLR byB6.PLderived (Thy-
1.2 - ) CD4+ T cells prepared from these mice at 10 wk
post-grafting are shown in Table 1 . It can be seen that, both
for LN cells and mature thymocytes, the H-2b CD4+ cells
from mice given host-type (B6 x CBA)Fi TG showed
strong tolerance to host H-2k APC but responded well to
third-party bm12 APC (group 3) . By contrast, CD4+ cells
from mice with H-2b TG gave definite responses to H-2kAPC (group 4) ; though significant, these responses were
nevertheless considerably lower than the control responses
of normal H-26 CD4+ cells (group 1) .
To examine whether the partial tolerance seen in the above
mice reflected incomplete disappearance of host APC after
irradiation, the interval between BMR and TG was extended
from 5 wk (Table 1) to 6 mo (Table 2) . Under these condi-
tions, the LN CD4+ cells differentiating in H-26 TG
showed no detectable tolerance to the H-2k antigens of the
host (Table 2) . The same findings applied to mature CD4+
(8 - ) cells prepared from the TG of the chimeras (Table 3) .
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Figure 1. Host Ia expression in
spleens of (B6 x CBA)Fj and long-
term B6.PL- FlBMC. Cryostat sec-
tions of spleens from a normal (B6 x
CBA)Fl mouse, and a 6-mo B6.PL
Fl BMCwere stained for expression of
1-Ak and I-Ek, as described in Materials
and Methods . (A) Low power (x40)
view of normal Ft spleen stained for
I-Ak ; staining is evident throughout
the spleen . (B)High power (x100) view
ofA: staining is evident in the red pulp
(rp), the marginal zone (mz), and the
follicles (f), and periarteriolar lympho-
cyte sheaths (pals) of the white pulp;
the centralarteriole (ca) is arrowed . (G)
Low power (x40) view of B6 (I-Ab)
spleen stained for I-Ak ; except for the
punctate staining of cells in thered pulp
(indicative of cells with endogenous per-
oxidase activity), no staining is ap-
parent. (D) Lowpower (x40) view of
B6.PL- Fl BMC spleen stained for
I-Ak ; patchy staining in the white pulp
and striatestaining ofred pulp sinusoids
is evident . (E) Highpower (x100) view
ofD; staining of the white pulp is
limited to focal areas in follicles; there
is no staining in the pals or mz. (F)
High power (x200) view ofspleen from
B6 PL -+ FlBMC stained for I-Ek; the
pattern ofstaining isessentially the same
as inE (note that the magnification is
higher forF than for E, and thatF and
E involved different fields) . (G) Low
power (x 40) viewof spleen from B6.PL
Fl BMC pretreated with IFN-.y
(Materials and Methods) ; strong stain-
ing is evident throughout the spleen.
(H) High power (x100) view of G ;
strong staining ofstromal cells (but not
hemopoietic cells) is seen throughout
the white pulp.
These data on TG mice contrasted with the strong tolerance
seen in control parent - F, chimeras, i .e ., where the CD4+
cells differentiated in the endogenous thymus of the host (Table
2, bottom group) .
Recently, we observed that CD4+ cells from B6 (I-E- )
-+ (B6 x CBA)F, (I-E+) chimeras show considerable
(50-70%) deletion of V011+ cells (7); in normal mice,
V011+ cells are selectively deleted in I-E+ mice . V011 ex-
pression on T cells from the 6-mo TG mice discussed above
areshown in Table 4 . It can be seen that, in marked contrast
to normal (B6 x CBA)Fj mice, V011+ cells were notTable 1 .
￿
Primary MLR by CD4' Cells Generated in Tx.Ir.BMR (H-2bxH--2k)F, Mice Given H-2b Stem Cells Followed S wk
Later by H-2b vs . F, Thymus Grafts
Tx .Ir . BMR mice were prepared as described in Materials and Methods and the text . To ensure that the T cells generated in the Tx.1r.BMR mice
were not contaminated with radioresistant cells present in theTG at the time of grafting, the mice received Thy-1.1+ BM cells (B6.PL) and Thy-1.2+
TG . Purified CD4+ CD8 - T cells depleted of Thy-1.2+ cells were prepared from LN and the thymus of the hosts at 10 wk post-grafting and
used as responder cells (101) in MLR with irradiated spleen cells (5 x 101) as stimulators. The data show mean responses for triplicate cultures
harvested on day 4 . Note that, to prevent responses to Mls- determinants, CBA/Ca rather than CBA/J stimulators were used .
Table 2 .
￿
Primary MLR by CD4' Cells Generated in Tx.Ir.BMR (H-2b x H-21)F, Mice Given H-2b Stem Cells Followed 6 mo Later
by H-2b Thymus Grafts: MLR by CD4' Cells from LN
MLR: ['H]TdR incorporation
with stimulators :
Tx.1r.BMR (B6 x CBA)F1 mice were prepared as described in Table 1, except that thymus grafting was delayed for 6 mo after irradiation and
BM reconstitution . Cell suspensions from LN were prepared at 9 wk after thymus grafting . Control parent -+ F1 chimeras were made by exposing
normal (euthymic) (B6 x CBA)F1 mice to 1,300 rad and reconstituting these mice with B6 BM cells ; 3 mo later, these mice received further irradi-
ation (1,000 rad) followed by reconstitution with B6.PL BM ; these mice are abbreviated "B6.PL- Ir (B6 x CBA)F1" in the table . As in Table
1, all cell suspensions were treated with anti-Thy-1 .2 mAb + C before use . Primary MLR were assayed as for Table 1, except that a higher dose
of responder cells (2 x 105) was used .
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CD4'-enriched responders (2 x 101)
Tissue source
of responders
Day of
MLR
B6 .PL
(H-2b)
(B6 x CBA)F1
(H-2b-k)
bm12
(H-2bm'2)
Response to H-2k/
response to H-2bm12
cpm x 16P
Normal B6 .PL LN 3 2.3 37.4 42.6 0.9
4 4.4 76.4 64.5 1.2
Normal (B6 x CBA)F1 LN 3 1.4 1.9 33.0 <0.1
4 2.9 3.8 78.4 <0.1
B6.PL BM - Tx.Ir (B6 x CBA)F1 + B6 TG LN 3 2.5 73.6 61 .9 1 .2
4 4.4 76.4 64.5 1 .2
B6 .PL- Ir (B6 x CBA)F1 (non-Tx) LN 3 1 .1 5.2 45.9 0.1
4 2 .3 15.4 95.5 0.1
Group CD4'-enriched responders (101)
Tissue source
of responders
['H]TdR incorporation
with stimulators :
B6.PL CBA bm12
(H-2b) (H-2k) (H-2b,n12)
Response to H-2k/
response to H-26'°'2
cpm x 10'
1 Normal B6.PL LN 1.5 146.5 80.8 1.8
Thymus 0.3 49.7 69.4 0.7
2 Normal (B6 x CBA)F1 LN 2.3 3.0 125.8 < 0.1
Thymus 0.2 0.3 56.4 < 0.1
3 B6.PL BM --> Tx.Ir (B6 x CBA)F, LN 0.2 3.1 60.0 < 0.1
with (B6 x CBA)F, TG Thymus 0.2 0.4 35 .2 < 0.1
4 B6 .PL BM --> Tx.Ir (B6 x CBA)F1 LN 0.6 26.4 51.7 0.5
with B6 TG Thymus 0.2 28.3 68.2 0.4Table 3.
￿
Primary MLR by CD4* Cells Generated in Tx.Ir.BMR (H-2 6 x H-24)F, Mice Given H-26 Stem Cells Followed 6 mo Later
by H-2b Thymus Grafts: MLR by CD4* Cellsfrom LN vs. Thymus
MLR: [3H]TdR incorporation
(cpm x 103)
with stimulators :
As for Table 2, except that the CD4* cells were prepared both from LN and the TG.
Table 4.
￿
VA11 Expression on LN T Cells Generated in Tx.Ir.BMR (H-2" x H24)F, Mice Given H-2a Stem Cells Followed 6 mo
Later by H-26 Thymus Grafts
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LN T cells from normal mice and the TG mice used in Tables 2 and 3 were double stained for Vsll (RR3-15) or Vs8 .1 + 8.2 (KJ16 mAb) vs .
CD4 or CD8 and analyzed by flow cytometry using two-channel immunofluorescence (Materials and Methods). For the TG mice, the data were
calculated with respect to Thy-1.1 * cells.
CD4*-enriched responders (2 x 105)
Tissue source
of responders
Day of
MLR
B6.PL
(H-2b)
CBA
(H-2t)
bm12
(H-2112)
Response to H-2k/
response to H-2bmtz
Normal B6.PL LN 3 3.4 86.7 41.7 2.1
4 4.1 219.0 89.3 2.5
Thymus 5 0.1 49 .0 20.5 2.4
Normal (B6 x CBA)Fi LN 3 2.3 2.4 43.2 < 0.1
4 3.5 5 .3 82.7 < 0.1
Thymus 5 0.3 0.1 28.6 < 0.1
B6.PLBM -+ TxJr (B6 x CBA)F, + B6 TG
Mouse no . 1 LN 3 2.2 62 .0 29.7 2.2
4 3.3 176 .9 72.0 2.5
Mouse no . 2 LN 3 2.7 112.4 32.4 3.7
4 3.8 158 .0 77.5 2.1
Mouse nos . 1 + 2 Thymus 5 0.1 104.6 44 .6 2.4
Percent of CD4* Percent of CD8`
Mice tested
No . of mice
tested
cells
Vsll
expressing :
Vo8
cells
Vsll
expressing
Vs8
Normal B6.PL 3 4.0 15.9 9.6 16.0
4.3 15.4 9.0 17.6
3.6 17.2 10.8 17.6
Mean = 4.0 16.2 9.8 17.1
Normal (B6 x CBA)Fl 3 0.0 14.4 2.7 14.2
0.5 15.8 2.8 15.7
0.0 15.1 5.3 15.3
Mean = 0.2 15.1 3.6 15.4
B6.PL BM- Tx.1r. (B6 x CBA)F, 4 7.6 25.6 12.5 22.1
with B6 TG 5.2 20.0 13.6 27 .3
5.6 20.8 17.6 29.5
3.9 23.0 14.2 24.4
Mean = 5.6 22.4 14.5 25 .9N
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Figure 2 .
￿
Vp expression on thoracic duct cells collected from irradi-
ated B6.PL mice (O), (B6 x CBA)F, mice (p), and B6.PL- F1 BMC
(" ) injected with normal B6 CD4+ cells. All mice were exposed to 900
rad 4 h before intravenous injection of 8 x 107 B6 CD4+ cells (LN cells
treated with J11d + anti-CD8 mAb + C) ; thoracic duct cannulas were
inserted 14 h later, and lymph was collected continuously for the intervals
shown. CD4+ cells in TDL were analyzed for expression of Vp11 (A),
V#5 (B), Vo8 (C), and for total numbers (D) . Vs expression on CD4+
cells was assessed by dual fluorescence and FACS® analysis (Materials and
Methods) . Mean values for individual mice (two to three mice/group) are
shown . It can be seen that B6 CD4+ cell transfer to B6.PL (I-E- ) hosts
led to no change in Vp ratios ; cell outputs inTDL declined progressively
and nearly all ofthe lymph-borne cells were small lymphocytes . B6 CD4+
cell transfer to normal F, (I-E+) hosts led to an initial marked decline
in V#11' and Vs5+ cells followed by an increase in these cells. This in-
crease corresponded with the appearance of blast cells in the lymph ; by
60 h, nearly all ofthe lymph-borne cells were blasts. The decrease in Vs8+
cells at 47-68 h presumably means that these cells were underrepresented
in the host-reactive early blast populations ; the later rise in Vs8' cells
at 69-84 h may be an indication of the marked over-representation of
V08+ cells seen at 2 wk post-transfer (see Fig. 6) . With B6 CD4+ cell
transfer to the chimeras, there was a minor decrease in Vs11+ and V05+
cells in early lymph collections and a slight increase in these cells in later
collections ; total cell outputs declined progressively, although blast cells
were apparent in late lymph collections . In the particularexperiment illus-
trated, all three groups of mice were treated with IFN-y before T cell
injection . Based onother experiments (see text), IFN-y treatment did not
enhance the degree ofVs selection seen in the chimeras or potentiate the
production of blast cells . It should be noted that in all three groups of
mice, the vast majority of the lymph-borne cells were donor-derived (Thy-
1.2+, H-2k- ) CD4+ cells.
deleted in Tx.Ir.BMR (B6 x CBA)F1 hosts given H-2b BM
plus H-2b TG .
Recognition ofHost Ia Antigen in Parent- F, Chimeras by
NormalTCells. One explanation for the lack of functional
tolerance in the TG mice is that host la expression in these
mice was simply too low to be relevant . To address this ques-
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tion, we used the technique of blood-to-lymph recirculation
of normal T cells through irradiated hosts (13, 18-21) . This
technique traps host-reactive T cells in the lymphoid tissues,
presumably as a manifestation ofT cell binding to host H-2
bearing cells. Trapping is manifested by a transient disappear-
ance of host-reactive T cells from TDL . In normal immuno-
genic donor/host combinations, this stage of negative selec-
tion is maximal at 1-2 d post-transfer. Thereafter, the progeny
of the trapped cells proliferate extensively and re-enter TDL
in large numbers as blast cells: the stage ofpositive selection .
For the experiments discussed below, B6.PL- 1,300 rad
(B6 x CBA)F, (F1) chimeras were exposed to 900 rad at 6
mo post-transfer and injected 2-4 h later with a large dose
(ti8 x 107) of purified CD4+ cells prepared from normal
B6 mice; as controls, B6 CD4+ cells were also transferred
to irradiated normal F 1 and B6.PL mice. In some of the ex-
periments, the host mice were pretreated with IFN-y for 3 d
before irradiation and T cell transfer . Thoracic duct cannula-
tion was performed -16 h after T cell injection, and TDL
were collected continuously over the next 4-5 d . The vast
majority (>90%) of the lymph-borne cells were of donor
(Thy-1.2+) origin.
V0 Expression.
￿
With I-E- -" I-E+ strain combinations,
negative and positive selection of host-I-E-reactive T cells is
demonstrable by monitoring V011 expression on the donor
T cells entering TDL (13) . As shown in Fig. 2, negative and
positive selection of Vo11+ cells and also V05+ cells was
conspicuous when B6 CD4+ cells were transferred to nor-
mal Fl hosts. The proportions of V#11+ and V05+ cells were
approximately eightfold below normal in early lymph col-
lections (16-34 h) but then rose to two- to threefold above
normal levels in later collections (47-68 h) before declining ;
Vg8+ cells, which are not I-E reactive, showed reciprocal ki-
netics . No alteration in V0 expression occurred when B6
CD4+ cells were transferred to syngeneic BUL hosts ; here,
the proportions of Vs11+, Vs5+, and Vo8+ cells in the
lymph remained constant throughout the 4-d drainage period.
In contrast to normal F, hosts, negative and positive selec-
tion of V011+ and V05+ cells was quite limited when B6
CD4+ cells were transferred to the chimeras. In a total of
four experiments, including two with mice pretreated with
IFN-y, the proportions of V011+ and Vs5+ cells in lymph
of the chimeras were reduced by 10-20% in early collections
and increased by 10-30% in late collections . The best evi-
dence for selection is shown in the experiment illustrated in
Fig. 2 in which the hosts were IFN-y pretreated . Based on
other experiments, however, it did not appear that IFN-y
pretreatment enhanced selection . The point to emphasize is
that negative and positive selection of V011+ and V#5+ (but
not V08+) cells was reproducibly demonstrated iritithe
chimeras but was clearly much less marked than in normal
F, hosts .
Activation Markers on Lymph-borneCells.
￿
With transfer of
B6 CD4+ cells to normal F1 hosts, the re-appearance of
Vp11+ and V,s5+ cells in TDL after the stage of negative
selection was associated with a marked (-10-fold) increase
in total numbers of cells in the lymph (Fig. 2 D) . By day
3, nearly all ofthese cells were blast cells. WithT cell transferCD '~
B6 CD4+-
￿
B6 CD4 *-"
B6.PL
￿
B6.PL-(B6xCBA1Ca)F,
BMC
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to the chimeras, by contrast, the cell content of the lymph
was no higher than in the control B6 CD4+ -+ B6.PL
group. This applied for the first 3 d post-transfer . Thereafter,
there was a slight (but reproducible) increase in TDL cell
numbers in the chimeras. This increase was associated with
the appearance of small numbers ofblast cells ; by day 4, blast
cells accounted for 20-40% of the lymph-borne cells (com-
pared with 10-20% for the B6 -" B6.PL group) .
Fig. 3 shows the expression of activation markers on the
lymph-borne cells collected at 69-84 h from the mice tested
in Fig. 2 ; the cells were double stained for Vs11 vs . 3G11,
a marker for virgin (resting)T cells (11) . Earlylymph collec-
tions from all three groups of mice consisted almost entirely
of small 3G11 + cells (data not shown) . For later lymph col-
lections (Fig. 3), the cells from the B6 --" B6.PL group re-
mained 3G11 + . By contrast, the blast cells (including Vs11+
blasts) generated in the B6- normal F1 group were nearly
all 3G11 - , indicative of activated T cells. With the B6
chimera group, 3G11 - cells began to appear in the lymph
at the end of day 3 and reached 60% of total cells by day
4-5 . The proportion of these cells was not significantly higher
in IFN-y-pretreated chimeras. Essentially similar findings ap-
plied when the cells were stained for other markers that dis-
tinguish resting and activated T cells, e.g ., Pgp-1 (data not
shown) .
T Cell Selection Measured by MLR .
￿
The experiments in
Fig. 4 were designed to examine whether acute blood to lymph
recirculation of B6 CD4+ cells through the B6.PL - F1
chimeras was able to cause trapping of functional T cells,
i.e., T cells responsive to normal F1 stimulator cells in vitro.
The donor cells were collected from the lymph at 20-40 h
post-injection and used as responder cells forMLR. The results
of three experiments are shown in Fig. 4 (A and B, C-E,
F -H); in one of the experiments (F-H), the chimeras (and
controls) were pretreated with IFN-y . As expected, B6
441
￿
Gao et al .
Figure 3.
￿
Vsll vs. 3G11 expression
on late collections ofthoracic duct cells
from the three groups ofmicedescribed
in Fig. 2 . The lymph-borne cells were
collected at 69-84h post-transfer. Cells
were stained for V#11 vs. 3G11 (a
marker on restingCD4+ cells) by dual
(B6 xCBAICa)F,
￿
fluorescence as described in Materials
andMethods . By adding thepercentages
in the lowertwo boxes, it can be seen
that the proportion of3G11- cells, i.e.,
cells with an activated phenotype, was
low in the CD4'' --" B6.PL group
(21.5%), intermediate in the CD4* -+
chimera group (56.7%), and veryhigh
in the CD4+ -+ normal F1 group
(88.8%) . Note that for the CD4+ -"
chimera group, 58% of the Vp11+
cells had an activated (3G11 -) pheno-
type. For earlier (<40 h) collections of
lymph, nearly all ofthe cells from each
group of mice were 3G11+ (data not
shown) .
B6 CD4 +-
V/311
CD4+ cells filtered through control B6.PL mice gave high
MLR to normal (B6 x CBA)F1 stimulators (I-A + I-E
difference) and weaker responses to B10.A(5R) stimulators
(I-E difference alone) . By contrast, B6 CD4+ cells filtered
through normal F 1 hosts were completely unresponsive to
F1 and 5R stimulators ; responses to third-partybm12 stimu-
lators were retained . The significant finding was that filtra-
tion of B6 CD4+ cells through the chimeras caused a par-
tial reduction in the response to F1 and 5R stimulators . This
reduction was specific because responses to bm12 remained
largely unchanged. Based on the magnitude of theMLR medi-
ated by graded doses ofresponder cells, the specificreduction
in the anti-Ft and anti-5R MLR by CD4+ cells filtered
through the chimeras vs. control B6.PL hosts amounted to
-50% (see Fig. 4 legend) . This also applied to chimeras
pretreated with IFN-y .
MLR by the lymph-borne cells collected from the above
threegroups ofmice at a later stage, i .e., 48-62 h post-injection,
are shown in Fig . 5 and Table 5 . At this stage, most of the
cells in the lymph of the B6 CD4+ -+ normal F1 group
were blast cells (see above) . These cells gave a low but
significant MLR to F1 stimulators, which peaked on day 2-3
and then declined to low levels by day 4 (Table 5) . This is
a typical response of recently activated T cells (21) . Quite
different results were seen with CD4+ cells collected from
the chimeras . As with cells from the control B6 - B6.PL
group, the lymph-borne cells from the chimeras gave typical
primary responses to F 1 stimulators with higher responses
on day 4 than on day 3 (Table 5) . Significantly, in contrast
to earlier lymph collections, there was no reduction in the
response to F1 (Fig. 5) or 5R (data not shown) stimulators .
This was seen in three separate experiments, including one
experiment with IFN-y-pretreated mice (Fig. 5, C and D) .
The above findings apply to cells recovered from the
chimeras at 50-60 h post-transfer, i.e., the early stage ofpositive
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Figure 4 .
￿
Acute recirculation ofB6 CD4+ cells through B6.PL -* F1
chimeras causes partial depletion of cells responsive to host-type F1 and
5R (host I-E only) spleen cells in vitro. Doses of 8 x 107 normal B6
CD4* cells were transferred intravenously to normal BUL mice (O),
normal F1 mice (0), or B6.PL- F1 BMC (") exposed to 900 rad 4 h
before (Fig. 2) ; the donor cells were recovered fromTDL at 20-40 h post-
injection. Various doses ofthesecells were used as responder cells for MLR
using F1, 5R, and bm12 irradiated spleen cells as stimulators ((9)
(Materials and Methods) ; MLR were harvested on day 4 or 5 . Theresults
of three different experiments are shown (A and B, C-E, andF-M; in
the third experiment (F-M, the mice were pretreated with IFN--y before
T cell injection . Each point represents the mean of triplicate cultures . It
can be seen that filtration of B6 CD4* cells through normal F1 hosts re-
duced the MLR to F1 and 5R by close to 100% but had little effect on
the response to third-party bm12 . B6 CD4* cells filtered through the
chimeras showed a partial reduction in the response to F1 and 5R . In cal-
culating the extent of this reduction, it is evident that the anti-F1 and
anti-5R responses mediated by a dose of 2 x 10 5 CD4* cells filtered
through the chimeras (e.g., in C and D) was roughly equivalent to the
responses mediated by 105 CD4* cells filtered through the control B6.PL
mice. Taking into consideration the response to bm12 (whichwas reduced
only in the third experiment [HI), the specific reduction in theMLR to
F1 and 5R by CD4* cells filtered through the chimeras ranged from 40
to 60% . This reduction was not accentuated in ON-.y-treated mice.
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Figure 5 .
￿
At day 3 after injecting irradiated B6.PL -+ Fl BMC with
normal B6 CD4* cells, the donor CD4 * cells in TDL show no reduc-
tion in MLR to host-type Pt spleen stimulators (0) . The results show
two experiments (A and B, and C and D) in which TDL were collected
at 48-62 h post-injection. These experiments were a continuation of the
first and third experiments in Fig. 4, and the symbols used in Figs. 4 and
5 are the same. In contrast to early lymph collections (Fig . 4), it can be
seen that the anti-F1 MLR mediated by CD4* cells collected from the
chimeras at 48-62 h post injection (" ) was no lower than the response
by CD4* cells passed through control B6.PL mice (O) ; note that, for
the cells passed through the chimeras, the higher response to Ft® in the
second experiment (C) was associated with an equivalent increase in the
response to bm126 (D).
selection . Since activated (3G11 - ) cells were rare in the
lymph at this time (3G11- cells appeared in TDL of the
chimeras only after 70 h, see above), it was important to study
the host reactivity of cells recovered at later stages . Testing
theMLR of cells collected from the chimeras at >60 h was
difficult because of low yields of cells. Instead, the following
approach was used. Groups of chimeras and control normal
F1 mice were exposed to sublethal irradiation (500 rad), in-
jected with a large dose ofB6 CD4+ cells, and then left for
16 d before thoracic duct cannulation . As shown in Fig. 6,
purified donor B6 CD4+ cells recovered from TDL of the
chimeras showed clear evidence of specific priming. MLR
to third-party (bm12) stimulators were unchanged (relative
to normal B6 CD4+ responders), but responses to F1 and
5R were markedly elevated and easily detectable with alow
dose of 5 x 104 responder cells (G, H, and n ; with higher
doses of responders, anti-F1 MLR were prominent as early
as day 2 of culture (D and E) . The selective priming to Ft
A B
F, QS bm12
B6 (8)
"aa4a~~
C D
F, (5 bm12©
B6 (3)Table 5 .
￿
MLR by B6 CD4' Cells Filtered through B6 - F, BMC and Recovered during Early Stage ofPositive Selection
' Cells recovered from lymph at 48-62 h post-injection .
and 5R stimulators was not associated with a significant al-
teration in Vs ratios (F) . Passaging B6 CD4+ cells through
the control normal F, mice gave somewhat different results.
These cells gave primed responses to Fl and 5R stimulators,
but this was associated with reduced responses to bm12 (rel-
ative to control B6 CD4' responders) (Fig. 6, A and B, and
data not shown) . Significantly, priming in normal F l mice
led to a marked alteration in Vo ratios : proportions of Voll+
and Vs5+ cells were considerably reduced whereas V#8+
cells were elevated (C), i.e., the converse of the ratios ob-
served during early positive selection (see Fig. 2) .
Discussion
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In previous studies, we reported that the environment of
parent - F l BM chimeras prepared with supralethal irradi-
ation (1,300 rad) was strongly tolerogenic for newly formed
T cells (7) . The donor-derived CD4' cells generated in the
host thymus gave only weakMLR to normal host-typeAPC
(spleen) in vitro and showed 50-70% depletion of host-l-E-
reactive VOW T cells. Since spleen and thymocyte suspen-
sions from the chimeras appeared to be completely depleted
of host-type APC, it was argued that tolerance to host la
antigens was induced intrathymically, presumably by thymic
epithelium . The possibility that tolerance was induced ex-
trathymically, however, could not be excluded. As shown here,
host la expression in the spleen of long-term chimeras was
not seen in sites occupied by BM-derivedAPC but was clearly
demonstrable in germinal centers, probably on follicular den-
dritic cells (which are reported to be non-BM derived (16]) ;
in IFN-y-treated chimeras, host la expression was also prom-
inent on vascular endothelium . Based on the findings ofothers
(see Introduction), one might expect such la expression on
"nonprofessional APC" to be highly tolerogenic, especially
for newly formed T cells .
The thymus grafting experiments reported here failed to
verify this prediction . Thus, when strain a stem cells differen-
tiated in strain a TG placed in long-term Tx.Ir.BMR (a x
b)Fl mice, the a-derived CD4+ cells gave high MLR to
normal host-type (a x b)Fi spleen cells in vitro and showed
no depletion of host I-E-reactive Vo11' cells ; this contrasted
with the strong tolerance seen when the chimeras received
(a x b)F, rather than a TG, i .e ., a situation where host Ia
was encountered on thymic epithelium . These results pro-
vide an alternative explanation for the TG experiments of
Bradley et al . (22) . In contrast to the present study, Bradley
et al . (22) observed strong host tolerance when TX.Ir.BMR
(a x b)F1 mice were given parent a stem cells and a parent
a TG. The authors concluded from this finding that T cells
are susceptible to prethymic tolerance. Since theTG were ap-
plied before irradiation, however, we suggest that the TG
were rapidly permeated with host BM-derived cells and that
these cells induced intrathymic tolerance of newly formed
T cells . We avoided this problem by leaving the Tx.1r.BMR
(a x b)Fi mice for a prolonged period, i.e., 6 mo, before
applying theTG . Grafting after a shorter interval, i .e., 5 wk,
led to partial tolerance.
A trivial explanation for the lack of tolerance seen in our
long-term TG mice is that host la expression in these mice
was simply too low to be relevant . Alternatively, the CD4+
cells in the TG mice might have been selectively tolerized
to unique self-peptide/la complexes expressed only on NBMD
cells (23) . These possibilities were assessed by injecting long-
term parent --" Ft chimeras with normal parental-strain
CD4+ cells. The expectation here was that, if host la ex-
pression in the chimeras were insignificant or tissue-specific,
the donor CD4+ cells would maintain their normal pattern
of blood-to-lymph recirculation and show unimpaired reac-
tivity to the host Ia antigens expressed on normal F l spleen
cells in vitro .
Filtration hosts (900 rad)
for B6 CD4' cells"
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for MLR (105 )
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(B6 x CBA)F,
d3 d4 d3
bm12
d4
cpm x 1i}'
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B6 CD4+ cells transferred to B6.PL- F1 chimeras for 2 wk
exhibit marked sensitization to the host antigens. Groups of B6.PL -
Fl chimeras and normal Fl mice were exposed to light irradiation (500
rad) and injected with a dose of 8 x 107 B6 CD4+ cells. The two groups
of mice were set up separately and were thus tested at different times .
At day 16 post-transfer, the mice were cannulated to obtain TDL, and
the lymph-borne cells (pooled from two to three mice/group) were used
as responder cells for MLR as in Figs. 4 and 5, and also tested for Vs
expression ; >90% of the lymph-borne cells were donor-derived CD4+
cells . (A and B) Early (day 2) MLR by normal B6 CD4+ cells (0) vs .
B6 CD4+ cells passed through the control normal F1 hosts (0); (C) Vs
expression on the passaged cells (hatched) vs. control normal B6 CD4+
cells (open) .The lymph-borne cells gave elevated responses to F1 m (rela-
tive to normal B6 CD4+ cells) and reduced responses to bm120 ; Vs11+
and Vs5+ cells were reduced whereas V08+ cells were elevated . Panels
(D-F) Day 2 MLR and Vs expression for normal B6 CD4+ cells (0,
open bars) vs . B6 CD4+ cells passed through the chimeras (" , closed ban) .
Relative to the control responder cells, the response to F1m was markedly
elevated whereas the response to bm12G was near normal; Vs ratios re-
mained unchanged . (G-~ A time response for the MLR by cells passed
through the chimeras, using 5 x 104 responder cells and F1 , 5R and
bm12G . With this small (limiting) dose ofresponder cells, the responses
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In practice, recognition ofhost la antigens in the chimeras
appeared to be considerable . Thus, when the donor CD4+
cells were recovered from TDL of the chimeras 1-2 d post-
transfer and tested in vitro, the MLR to normal host-type
spleen cells in vitro was specifically reduced by -50% . A
priori, one might expect this selective trapping ofhost-reactive
CD4+ cells by antigen expressed onNBMD cells to be fol-
lowed by tolerance induction . This was not found . Instead,
the host-reactive CD4+ cells reappeared in the lymph at day
3 post-transfer. Interestingly, the lymph-borne cells collected
at this time (50-60 h) showed no obvious sign of activation .
This was in sharp contrast to CD4+ cells transferred to
normal Fl hosts; here, the lymph at day 3 contained large
numbers of blast cells that responded to host-type APC in
vitro with accelerated kinetics. The implication, therefore,
is that Ia expression in the chimeras was not overtlyimmuno-
genic but simply slowed the rate at which the la-reactive cells
moved through the lymphoid tissues : after a transient period
of trapping in the spleen and other organs, most ofthe host-
reactive cells re-entered the circulation still in a resting state .
This explanation is in line with the report of Ford et al . (24)
thatT cell trapping in vivo does not necessarily result in cell
activation. In parent - normal F l combinations, these
workers found that up to 50% of the (selectively) trapped
cells failed to enter cell cycle . The subsequent fate of these
cells was not studied.
Host la expression in the chimeras was clearly immuno-
genic for a small proportion of the injected CD4+ cells. Ac-
tivated (3G11 - ) CD4+ cells were rare in the chimeras be-
fore day 3 post-transfer but were readily detectable at later
stages and accounted for 40-60% of the lymph-borne cells
by day 4-5 (compared with <20% for syngeneic transfers) .
Progressive expansion of these cells presumably accounted for
the striking degree of priming observed when CD4+ cells
were left in the chimeras for a 2-wk period. At this stage,
the lymph-borne CD4+ cells from the chimeras gave very
powerful and specific responses to host Ia antigens in vitro .
Indeed, the level of priming in the chimeras was as high or
higher than when CD4+ cells were transferred to normal
F l hosts.
Although the kinetics and duration ofCD4+ cell priming
in the chimeras vs. normal Fl hosts has yet to be examined
in detail, it is notable that V0 ratios in the two groups of
primed cells were quite different . With the I-E- - I-E+
combinations used, transfer of CD4+ cells to normal Fl
hosts induced strong negative selection (trapping) and posi-
tive selection (blast cell production) of host-I-E-reactive
V011+ and V05+ cells but no obvious selection of Vg8+ cells
(which are not I-E reactive) . Paradoxically, despite the marked
enrichment for VOW and V05+ cells in the blast popula-
tion generated at day 3 post-transfer, the primed cells col-
lected at 2 wk post-transfer showed a specific reduction in
to Ftm and SRO were far higher than with the control responders. These
responses reached a peak on day 3-4 (Fl ) or day 4-5 (5R), whereas the
response to bm12 peaked on day 5 .Vo11+ andVoS+ cells and a reciprocal increase in V08+ cells .
CD4+ cell transfer to the chimeras, by contrast, resulted in
only minimal changes in the frequency of Vo11+ and Vo5+
cells (even in IFN-y-treated hosts), despite the fact that the
CD4+ cells recovered at 2 wk post-transfer showed priming
to host I-E (5R) antigens . Although a full interpretation of
these findings will need further experimentation, two points
can bemade. First, the data indicate that, in addition to causing
substantial trapping, Ia expression in the chimeras was clearly
immunogenic for a proportion of normal parental strain
CD4+ cells . Second, the data on V0 ratios imply that
priming in the chimeras vs . normal Fl hosts was qualita-
tively different, which argues against the possibility that the
chimeras contained residual BM-derived host APC.
At face value, the strong T cell priming seen in the chimeras
at 2 wk post-transfer would seem to challenge the view that
T cell priming is under the control ofspecialized BM-derived
APC . The point to stress here is that, in terms of total blast
cell production, proliferation of the donor CD4+ cells in the
chimeras was far less prominent than in normal Ft hosts
(where proliferation was presumably driven by radioresistant
host APC) . As suggested above, T cell contact with follic-
ular dendritic cells (or otherNBMD cells) in the chimeras
was presumably overtly immunogenic for only a small propor-
tion of the donor CD4+ cells, perhaps a subset of very high
affinity cells . These cells eventually underwent substantial ex-
pansion, but only after a prolonged (2wk) period and under
conditions where competition withT cells responding to an-
tigen on typical APC was avoided . These "optimal" condi-
tions in vivo might be difficult to reproduce in vitro . The
precise specificity of the CD4+ cells primed in the chimeras
is still unclear. The possibility that these cells were selectively
primed to tissue-specific Ia antigens seems unlikely since
normal spleen cells were used to detect priming.
Since the environment of the chimeras proved to be im-
munogenic for normal CD4+ cells (albeit a small propor-
tion of these cells), one might expect to see comparable evi-
dence for immunogenicity in theTG mice . Two points should
be made here. First, it may be noted that for several of the
TG mice tested the LN CD4+ cells tended to give slightly
above normal MLR to host-type APC for early (day 3) re-
sponses (Table 3, see ratios on far right) . Second, it is in-
teresting that theTG mice eventually became ill and showed
lymphocytic infiltration in the liver suggestive o£ graft-vs .-
host disease (our unpublished data) . Alternatively, the path-
We thank B. Marchand for typing the manuscript .
ology seen in the TG mice might have been mediated by host
class I-reactive cells ; the issue of tolerance/immunity at the
level of CD8+ cells is still under study.
The data in this paper are difficult to reconcile with the
popular view that antigen presented on cells other than typ-
ical BM-derivedAPC is tolerogenic (25) . Although this no-
tion is well supported by in vitro experiments, evidence that
antigen on "nonprofessional APC" induces tolerance in vivo
is quite sparse . Indeed, given the evidence that in vitro toler-
ance induced by chemically fixed APC can be blocked by by-
standerAPC (25), it is difficult to envisage how this mecha-
nism oftolerance could operate in vivo (where bystanderAPC
are presumably numerous) . In the case ofsolid tissue allografts,
it is well accepted that depleting grafts of "passenger leuko-
cytes" impairs rejection (26) . Such grafts rarely induce true
tolerance, however, and the lack of rejection can be attrib-
uted to sequestration of the graft from the host's immune
system . Perhaps the best evidence that antigen on nonprofes-
sional APC can be tolerogenic in vivo has come from the
finding thatsome (3, 27), though not all (28-30), transgenic
lines expressing foreign la antigens selectively in the pancreas
show tolerance at the level of CD4+ cells . A puzzling fea-
ture of this model is that tolerance is evident in the thymus
as well as in the periphery, a clear contrast to the TG mice
reported here where neither thymus norLN showed evidence
of tolerance induction . The site and mechanism of tolerance
induction in the transgenic mice is still unclear. With regard
to the present data, it is of particular interest that immunity
rather than tolerance occurred when the above transgenic lines
were injected with normal wild-type T cells (although only
when the host was irradiated or T depleted) (27) . This finding
does not fit easily with the notion that tolerance in the trans-
genic lines is simply a reflection of defective antigen presen-
tation . However, these data from transgenic mice do agree
closely with the current observation that transfer of CD4+
cells to long-term chimeras led to immunity rather than
tolerance .
The factors controlling tolerance induction of mature T
cells are clearly still poorly understood . Recent work has sug-
gested that the distinction between tolerance and immunity
can be quite subtle. Thus, under certain conditions, T cell
tolerance can be the end result of a powerful immune response
(31) . In light of this and the above findings, the notion that
immunity and tolerance simply reflect different modes of an-
tigen presentation will need to be re-evaluated.
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